Researchers modify natural cell packages to deliver drugs to cancer

Natural transport systems become drug vehicles

Cells naturally produce tiny bubble-like structures called extracellular vesicles that move proteins and other molecules throughout the body. Researchers at Carnegie Mellon University have found a way to modify these natural packages to carry therapeutic cargo instead. This approach uses biological mechanisms already present in the human body to target specific cells.

Platform avoids unintended cell targets

Christopher Blum, a doctoral candidate in chemistry, created a platform that changes how these vesicles interact with different cell types. The new system allows treatments to reach cancer cells while avoiding healthy tissue that might absorb the carriers by mistake. This precision aims to improve drug effectiveness and reduce side effects for patients.

Study published in scientific journal

The research findings regarding this customizable DNA labeling technique were recently published in ACS Applied Bio Materials. The study demonstrates a low-cost method for engineering natural carriers to address challenges in current drug delivery systems.